State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of 4,174,260 shares of Replimune Group Inc common stock as of September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: State Street Corporation reported beneficial ownership of 4,174,260 shares of Replimune Group Inc common stock.
  • Percent of class: The reported stake represents 4.4% of Replimune Group Inc's outstanding common stock.
  • Shared voting power: State Street reported shared voting power over 4,080,714 shares, with sole voting power of 0.
  • Shared dispositive power: The filing disclosed shared dispositive power over 4,174,260 shares, with sole dispositive power of 0.
  • Subsidiaries involved: Three subsidiaries were identified as acquiring the reported securities: SSGA Funds Management, Inc., State Street Global Advisors Europe Limited, and State Street Global Advisors Trust Company, each classified as an investment adviser.
  • Event date: The date of the event requiring this filing was September 30, 2026.

State Street Corporation Reports Passive Stake in Replimune Group Inc

State Street Corporation, a holding company organized in Massachusetts with principal offices at One Congress Street, Suite 1, Boston, MA 02114, filed a Schedule 13G disclosing its beneficial ownership position in Replimune Group Inc, a biopharmaceutical company whose principal executive offices are located at 500 Unicorn Park Drive, 3rd Floor, Woburn, Massachusetts, 01801. The filing covers common stock with CUSIP number 76029N106 and reflects holdings as of September 30, 2026.

According to the filing, State Street Corporation reported an aggregate of 4,174,260 shares beneficially owned, equating to 4.4% of the class. The company disclosed zero sole voting power and zero sole dispositive power over these shares. Shared voting power was reported at 4,080,714 shares, while shared dispositive power covered the full 4,174,260 shares. The filing identified three subsidiaries through which the securities were acquired: SSGA Funds Management, Inc. (classified as an investment adviser), State Street Global Advisors Europe Limited (investment adviser), and State Street Global Advisors Trust Company (investment adviser).

State Street Corporation is classified in the filing as a parent holding company (type "HC"). The Schedule 13G was signed by Alok Maheshwary, Senior Vice President, on November 9, 2026. The certification in the filing states that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer." Item 5 of the filing notes ownership of 5 percent or less of the class, and Item 6 indicates the ownership of more than 5 percent on behalf of another person is "NOT APPLICABLE."

What Was Disclosed

State Street Corporation disclosed a 4.4% beneficial ownership position in Replimune Group Inc common stock totaling 4,174,260 shares as of September 30, 2026, held through three investment adviser subsidiaries with shared but no sole voting or dispositive power.